TP53 and acute myeloid leukemia: Indeed, synergistic potentiation of vorinostat-mediated apoptosis by the Chk1 inhibitor MK-8776 has been demonstrated in various AML cell lines, both p53-wild type and -deficient, as well as in those bearing FLT3-ITD [115].